These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34817788)

  • 21. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
    Himmelmann A; Brücker R
    Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and genetic features of MDS associated with VEXAS syndrome].
    Kunimoto H
    Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
    Lecoeuvre H; Le Gall F; Le Naoures C; Vignon-Pennamen MD; Lamaison C; Kammerer-Jacquet SF; Lescoat A; Oger E; Pastoret C; Dupuy A
    Clin Exp Dermatol; 2024 Jul; 49(8):825-833. PubMed ID: 38366665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular and orbital manifestations in VEXAS syndrome.
    Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R
    Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
    Olteanu H; Patnaik M; Koster MJ; Herrick JL; Chen D; He R; Viswanatha D; Warrington KJ; Go RS; Mangaonkar AA; Kourelis T; Hines A; Gibson SE; Peterson JF; Reichard KK
    Am J Clin Pathol; 2024 Jun; 161(6):609-624. PubMed ID: 38413044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
    Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
    JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic Mutations in
    Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
    N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
    Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
    Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on VEXAS syndrome.
    Al-Hakim A; Savic S
    Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
    Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEXAS syndrome.
    Grayson PC; Patel BA; Young NS
    Blood; 2021 Jul; 137(26):3591-3594. PubMed ID: 33971000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEXAS Syndrome-Review.
    Zhang Y; Dong X; Wang H
    Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEXAS syndrome: A 2-case series report.
    Mayo-Juanatey A; Fernández-Llavador MJ; Fernández-Garcés MDM; Valls-Pascual E; Alegre-Sancho JJ
    Reumatol Clin (Engl Ed); 2024; 20(6):341-344. PubMed ID: 38918162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEXAS Syndrome: A Novelty in MDS Landscape.
    Templé M; Kosmider O
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern.
    Iannone C; Pellico MR; Campochiaro C; Tescaro L; Zompatori M; Caminati A; Harari S; Caporali R
    Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
    Wu Z; Gao S; Gao Q; Patel BA; Groarke EM; Feng X; Manley AL; Li H; Ospina Cardona D; Kajigaya S; Alemu L; Quinones Raffo D; Ombrello AK; Ferrada MA; Grayson PC; Calvo KR; Kastner DL; Beck DB; Young NS
    Cell Rep Med; 2023 Aug; 4(8):101160. PubMed ID: 37586319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
    Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
    Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.